Strategic Plan

Clinical Immunology Society Strategic Plan Summary

The Clinical Immunology Society (CIS) Executive Committee convened in the Summer of 2023 to establish a new five-year strategic plan, building off the original strategic plan from 2019 - 2023. This plan extending into 2028, will provide guidance into the activities of the CIS to ensure that every action is in line with the goals and missions of the society.




During the next five years, CIS is committed to providing clear and timely communication between leadership and the membership at large. Additionally the communication strategies will extend further than the membership alone. The following tasks will be implemented to achieve this goal:

  • Enhanced social media presence
  • Regular updates to the membership with Society updates
  • Ensure CIS representation in a high quality journal
  • Update the CIS Diagnostic Laboratory Directory


CIS continues to pride itself on its existing partnerships and the founding of the International Alliance for Primary Immunodeficiency Societies (IAPIDS). CIS will continue to pursue these current partnerships and, over the next five years, the CIS will partner with the following organizations:

  • The International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
  • American Society of Pediatric Hematology/Oncology (ASPHO)
  • The Histiocyte Society
  • North American Immuno-Hematology Clinical Education & Research (NICER)

Additionally, CIS will continue to partner with IAPIDS to develop proactive and strategic engagements that benefit the partner societies, as well as their members.



The CIS leadership understand that the members are the cornerstone of the Society. While all of these initiatives are meant to serve the Membership, there are specific ways in which CIS will grow the membership, and provide resources specifically to benefit its members. Some of these initiatives include:

  • Invigorate the listserv with contributions from the CIS committees and leadership
  • Establish a mentorship program for early career immunologists
  • Develop abstract awards
  • Create member resources like slide sets relevant to clinical and mechanistic immunology
  • Provide free membership to clinical immunology trainees
  • Highlight the work of CIS committees during the Annual Meeting and on social media


Because the work that all CIS members conduct on a daily basis is so innovative to the field at-large, the services that it offers should do the same:

  • The Diversity & Inclusion Committee will establish diversity and inclusion holistically across the Society
  • Work with established podcasts in clinical immunology to participate as guest speakers
  • Align the benefits and offerings of the Society with the evolving needs of the membership
  • Establish awards and grants in honor of the pioneers in clinical immunology
  • Pursue new initiatives to raise funds for the CIS Foundation


CIS is dedicated to providing cutting-edge resources for its members to promote excellence in research and clinical care. CIS will focus on:

  • Enhancing networking at the Annual Meeting by recording in-person meetings and posting them for those registered for use after the meeting
  • Incorporating additional topics into Annual Meeting relevant to the educational needs of the membership (eg, secondary immunodeficiency; private practice)
  • Continuing to advance and innovate the training of fellows and early career immunologist through dedicated CIS sponsored schools
  • Partnering with AAAAI and ACAAU to establish pre-conference educational sessions
  • Continuing partnerships with other organizations for Early Career Immunologist (ECI) webinars


Advocacy on behalf of the patient, clinician, and researcher is an extremely important core value of CIS. The leadership will refocus this core value in the following ways:

  • Refresh current advocacy resources on the CIS website
  • Establish position statements related to healthcare reimbursement and payer advocacy
  • Partner with IDF and other aligned organizations to advocate and lobby on behalf of our members and patients with local and national legislatures
  • Create Practice Considerations manuscripts (eg, management of the immunologic complications of Down Syndrome)
  • Work with the Investigators of CIS Committee to promote the advancement of clinicians and scientists in the field of Clinical Immunology
  • Explore additional advocacy topics for position statements and practice guidelines